© 2005 European Society for Medical Oncology
Original article |
Inhibitory effect of recombinant adenovirus carrying melittin gene on hepatocellular carcinoma
Department of Chinese Traditional Medicine, Changhai Hospital, Second Military Medical University, Shanghai, China
* Correspondence to: Dr C.-Q. Ling, Changhai Hospital, Second Military Medical University, 174 Changhai Road, 200433 Shanghai, China. Tel: +86-21-65562275; Fax: +86-21-65562275; Email: libai9{at}126.com or libaismmu{at}sina.com
Objectives: To search for a new clinical application of melittin (Mel): treating hepatocellular carcinoma with Mel gene.
Methods: Recombinant adenoviruses carrying the Mel gene and 
-fetoprotein (AFP) promoter (Ad-rAFP-Mel) were constructed through a bacterial homologous recombinant system. The efficiency of adenovirus-mediated gene transfer and the inhibitory effect of Ad-rAFP-Mel on the proliferation of hepatocarcinoma cells were determined by X-gal stain and MTT assay, respectively. The tumorigenicity of hepatocarcinoma cells transfected by Ad-rAFP-Mel and the antitumor effect of Ad-rAFP-Mel on transplanted tumor in nude mice were detected in vivo.
Results: The Mel mRNA was transcribed in BEL-7402 hepatocellular carcinoma cells transducted by Ad-rAFP-Mel. The efficiency of adenovirus-mediated gene transferred to BEL-7402 cells was 100% when the multiplicity of infection of Ad-rAFP-Mel was 10 in vitro, and was also high in vivo. The inhibitive rates of Ad-rAFP-Mel and Ad-rAFP for BEL7402 cells were 66.2 ± 2.7% and 2.9 ± 2.3% (t=30.83, P=6.6 x 10–6) by MTT assay. The inhibitive rates of Ad-CMV-Mel for BEL7402, SMMC7721 and L02 cells were 58.9 ± 9.6%, 65.9 ± 3.8% and 31.7 ± 1.2%, respectively, and of Ad-rAFP-Mel were 66.2 ± 2.7%, 16.1 ± 6.6% and 7.5 ± 3.3%, respectively (t=1.27, P=0.27; t=11.31, P=3.5 x 10–4; and t=12.12, P=2.7 x 10–4 versus the Ad-CMV-Mel group in the same cells). The tumorigenicity rates of hepatocarcinoma cells transfected by Ad-rAFP-Mel were decreased. A significant antineoplastic effect was detected on transplanted tumor in nude mice by intratumoral injection of Ad-rAFP-Mel.
Conclusions: Ad-rAFP-Mel can inhibit specifically proliferation of AFP-producing human hepatocarcinoma cells in vitro and in vivo. This suggests that animal toxin gene can be used as an antitumor gene.
Key words:
-fetoprotein, gene therapy, hepatocellular carcinoma, melittin gene, recombinant adenovirus
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Zheng, F. Yuan, Y. Li, F. Zhu, P. Hou, J. Li, X. Song, M. Ding, and H. Deng Claudin-6 and Claudin-9 Function as Additional Coreceptors for Hepatitis C Virus J. Virol., November 15, 2007; 81(22): 12465 - 12471. [Abstract] [Full Text] [PDF]
|
|